These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12650636)

  • 1. Violation of homogeneity: a methodologic issue in the use of data mining tools.
    Lilienfeld D; Nicholas S; Macneil D; Kurjatkin O; Gelardin T
    Drug Saf; 2003; 26(5):363-4; author reply 364-6. PubMed ID: 12650636
    [No Abstract]   [Full Text] [Related]  

  • 2. A data mining approach for signal detection and analysis.
    Bate A; Lindquist M; Edwards IR; Orre R
    Drug Saf; 2002; 25(6):393-7. PubMed ID: 12071775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of reporting bias in the analysis of spontaneous reporting data.
    Ghosh P; Dewanji A
    Pharm Stat; 2015; 14(1):20-5. PubMed ID: 25376637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian confidence propagation neural network.
    Bate A
    Drug Saf; 2007; 30(7):623-5. PubMed ID: 17604417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs.
    Bate A; Lindquist M; Orre R; Edwards IR; Meyboom RH
    Eur J Clin Pharmacol; 2002 Oct; 58(7):483-90. PubMed ID: 12389072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A challenge to the data miners.
    Lilienfeld DE;
    Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):881-4. PubMed ID: 15558812
    [No Abstract]   [Full Text] [Related]  

  • 7. Accounting for multiplicity in the evaluation of "signals" obtained by data mining from spontaneous report adverse event databases.
    Gould AL
    Biom J; 2007 Feb; 49(1):151-65. PubMed ID: 17342957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data mining in pharmacovigilance: lessons from phantom ships.
    Hauben M; Reich L; Van Puijenbroek EP; Gerrits CM; Patadia VK
    Eur J Clin Pharmacol; 2006 Nov; 62(11):967-70. PubMed ID: 16896782
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of stratification on adverse drug reaction surveillance.
    Hopstadius J; Norén GN; Bate A; Edwards IR
    Drug Saf; 2008; 31(11):1035-48. PubMed ID: 18840023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database.
    Ståhl M; Lindquist M; Edwards IR; Brown EG
    Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):355-63. PubMed ID: 15170764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China.
    Li C; Xia J; Deng J; Jiang J
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):593-600. PubMed ID: 18432629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal detection in FDA AERS database using Dirichlet process.
    Hu N; Huang L; Tiwari RC
    Stat Med; 2015 Aug; 34(19):2725-42. PubMed ID: 25924820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing data mining methods on the VAERS database.
    Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal detection in pharmacovigilance: empirical evaluation of data mining tools.
    Chan KA; Hauben M
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):597-9. PubMed ID: 16134080
    [No Abstract]   [Full Text] [Related]  

  • 15. Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting.
    Ahmed I; Haramburu F; Fourrier-Réglat A; Thiessard F; Kreft-Jais C; Miremont-Salamé G; Bégaud B; Tubert-Bitter P
    Stat Med; 2009 Jun; 28(13):1774-92. PubMed ID: 19360795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computerized system for signal detection in spontaneous reporting system of Shanghai China.
    Ye X; Fu Z; Wang H; Du W; Wang R; Sun Y; Gao Q; He J
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):154-8. PubMed ID: 19115240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets.
    Orre R; Bate A; Norén GN; Swahn E; Arnborg S; Edwards IR
    Int J Neural Syst; 2005 Jun; 15(3):207-22. PubMed ID: 16013091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database.
    Bate A; Lindquist M; Edwards IR
    Fundam Clin Pharmacol; 2008 Apr; 22(2):127-40. PubMed ID: 18248442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data mining in spontaneous reports.
    Bate A; Edwards IR
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):324-30. PubMed ID: 16611210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
    Szarfman A; Machado SG; O'Neill RT
    Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.